Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Ethosuximide level

Immunology & Autoimmune

Ethosuximide concentrationETX levelZarontin level

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the amount of ethosuximide in your blood. Ethosuximide is an anti-seizure medication most commonly used to treat absence seizures. Measuring the drug in your bloodstream helps your care team understand how your body is handling the medication.

Blood levels are usually checked after you have been on a stable dose for a period of time and at a consistent time in relation to your last dose, often just before the next dose. The result reflects how well you absorb, distribute, metabolize, and clear the medicine.

Why it matters

Keeping ethosuximide within a therapeutic window helps control seizures while limiting side effects. Your clinician may order this test when starting treatment, after a dose change, if you have breakthrough seizures, if you develop side effects, or to check adherence.

Levels can be affected by other medicines, liver or kidney function, age, and pregnancy. Monitoring can guide safe dose adjustments, reduce the risk of toxicity such as stomach upset, fatigue, or rare blood cell problems, and support effective seizure control.

Understanding your results

Your result is interpreted together with your dose, the timing of the blood draw relative to your last dose, seizure control, and any side effects. A level that is lower than expected may suggest missed doses, poor absorption, or faster drug clearance. A level that is higher than expected may increase the chance of side effects.

Do not change your dose on your own. If your result raises concern, your clinician may confirm the timing of the sample, review other medications, check liver or kidney function, and repeat the test. The goal is to find a dose that keeps you seizure free with the fewest side effects.

Reference ranges

280700 umol/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Ethosuximide level

  • Timing of sample

    Blood is best drawn at a consistent time in relation to your last dose, typically just before the next dose. Drawing too soon after a dose can give a higher value that does not reflect the baseline level.

  • Adherence and absorption

    Missed doses, vomiting, or gastrointestinal issues can lower the measured level. Taking the medication as prescribed and noting any stomach illness helps interpret results accurately.

  • Drug interactions

    Other antiseizure drugs and some antibiotics can change ethosuximide metabolism. Valproate may raise levels, while enzyme-inducing medicines may lower them. Always share your full medication list.

  • Liver and kidney function

    Ethosuximide is processed by the liver and excreted by the kidneys. Impaired function can change clearance, leading to higher or lower levels for a given dose.

  • Age and body composition

    Children, adolescents, and older adults can handle the drug differently due to changes in metabolism and distribution, which may influence the concentration seen on testing.

  • Pregnancy

    can increase drug clearance and volume of distribution, which may lower levels at the same dose. Closer monitoring is often needed during and after pregnancy.

  • Sample handling and method

    Using serum or plasma consistently and proper processing reduces variability. Different laboratory methods can yield slightly different results, so follow-up testing is best done at the same lab.

  • Alcohol and illness

    Alcohol use and acute illnesses can affect metabolism and adherence. Tell your clinician about recent alcohol intake or illness when reviewing your result.

2026

References

  1. McGill University Health Centre. (2009, September 22). Ethosuximide (Task CD 695404). Laboratory reference ranges.
  2. Patsalos, P. N., Spencer, E. P., & Berry, D. J. (2018). Therapeutic drug monitoring of antiepileptic drugs in epilepsy: An update. Therapeutic Drug Monitoring, 40(5), 526–548. External link
  3. Glauser, T., Ben-Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., ... & Tomson, T. (2013). ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia, 54(3), 551–563. External link